🇺🇸 FDA
Company

ONCOLYTICS

ONCOLYTICS BIOTECH INC

ONCY biotech USA

Quick answer

ONCOLYTICS is a biotech company (ONCY) headquartered in SAN DIEGO, CA, USA with 22 tracked pipeline programs.

Pipeline (22)

project

REOLYSIN

Carcinoma, Squamous Cell of the Head and Neck

Phase 3 · mab · completed

2 trials project

Bevacizumab

Ras-mutated Metastatic Colorectal Cancer

Phase 2 · small_molecule · active

1 trials project

Docetaxel, Reolysin and Prednisone

Prostate Cancer

Phase 2 · small_molecule · completed

1 trials project

Folfox plus Bevacizumab and reolysin

Colorectal Cancer

Phase 2 · small_molecule · completed

1 trials project

Paclitaxel

Metastatic Breast Cancer

Phase 2 · small_molecule · completed

1 trials project

Paclitaxel

Breast Cancer Metastatic

Phase 2 · small_molecule · active

1 trials project

Pelareorep

Anal Cancer Metastatic

Phase 2 · small_molecule · active

1 trials project

Pelareorep

Anatomic Stage IV Breast Cancer AJCC v8

Phase 2 · mab · active

1 trials project

Pemetrexed and Reolysin (and safety run-in)

Non Small Cell Lung Cancer

Phase 2 · small_molecule · completed

1 trials project

REOLYSIN

Metastatic Pancreatic Adenocarcinoma

Phase 2 · mab · completed

1 trials project

REOLYSIN

Metastatic Melanoma

Phase 2 · mab · completed

1 trials project

REOLYSIN

Metastatic or Recurrent Squamous Cell Carcinoma of the Lung

Phase 2 · mab · completed

1 trials project

REOLYSIN®

Carcinoma, Non-small Cell Lung

Phase 2 · mab · completed

1 trials project

REOLYSIN®

Osteosarcoma

Phase 2 · mab · completed

1 trials project

Bortezomib

Recurrent Plasma Cell Myeloma

Phase 1 · small_molecule · completed

1 trials project

Carfilzomib

Recurrent Plasma Cell Myeloma

Phase 1 · small_molecule · completed

1 trials project

Lenalidomide or Pomalidomide

Multiple Myeloma

Phase 1 · small_molecule · active

1 trials project

Pelareorep

Breast Cancer

Phase 1 · mab · terminated

1 trials project

REOLYSIN®

Pancreatic Adenocarcinoma

Phase 1 · mab · completed

1 trials project

REOLYSIN®

KRAS Mutant Metastatic Colorectal Cancer

Phase 1 · mab · completed

1 trials project

REOLYSIN®

Malignant Glioma

Phase 1 · mab · completed

1 trials project

REOLYSIN®

Muscle-invasive Transitional Cell Carcinoma of the Bladder

Phase 1 · mab · terminated

1 trials

Patents (8)

patent

US 11542526

Oncolytic adenoviral vector and methods of use

Expires Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11246930

Reoviruses having modified sequences

Expires Mon Feb 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10596260

Reoviruses having modified sequences

Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10167452

Viral purification methods

Expires Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10039827

Reoviruses having modified sequences

Expires Mon Aug 02 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9610309

Liquid viral formulations

Expires Mon Mar 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9610352

Lyophilized viral formulations

Expires Mon Mar 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9365823

Virus clearance of neoplastic cells from mixed cellular compositions

Expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)